Sabby Management’s TransCode Therapeutics RNAZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,180
| Closed | -$113K | – | 52 |
|
|
2025
Q1 | $113K | Buy |
+8,180
| New | +$113K | 0.33% | 28 |
|
|
2024
Q2 | – | Sell |
-362
| Closed | -$229K | – | 50 |
|
|
2024
Q1 | $229K | Buy |
+362
| New | +$229K | 0.13% | 16 |
|
|
2023
Q4 | – | Sell |
-7
| Closed | -$126K | – | 73 |
|
|
2023
Q3 | $126K | Buy |
7
+2
| +40% | +$36K | 0.09% | 35 |
|
|
2023
Q2 | $433K | Buy |
+5
| New | +$433K | 0.35% | 27 |
|